- Approval comes days after Dr Anthony Fauci expressed cautious optimism about results of drug trial
- New York schools to remain closed for rest of academic year
- Trump says Whitmer should ‘make a deal’ with protesters
- Coronavirus – global updates
- See all our coronavirus coverage
- Get a fresh perspective on America – sign up to our First Thing newsletter
The Food and Drug Administration (FDA) has released additional information about its emergency use authorization (EUA) for remdesivir, the anti-viral drug that has shown some promise as a treatment for patients with Covid-19. Donald Trump announced the EUA earlier today.
Use of the drug will be authorized for adults or children who are hospitalized with suspected or confirmed Covid-19 and whose condition is “severe”, meaning they have low blood oxygen levels, need oxygen therapy, or are on a mechanical ventilator, the FDA said.
Donald Trump appears to have revised upward to 100,000 his expectations for the number of Americans who will die of Covid-19.
“Hopefully we’re going to come in below that 100,000 lives lost, which is a horrible number nevertheless,” Trump said at a White House event to honor people who are doing work related to the coronavirus pandemic, according to Reuters.